Kalvista Pharmaceuticals Inc (KALV) Directors and Executive Officers - CSIMarket
CSIMarket
 
Kalvista Pharmaceuticals Inc   (NASDAQ: KALV)

Kalvista Pharmaceuticals Inc

Officers & Directors


Kalvista Pharmaceuticals Inc. Executives and Directors:

- Edward W. Unkart, Director

- Nancy Stuart, Director

- Brian J.G. Pereira, Director and Chairman

- Patrick Treanor, Director

- William Fairey, Director

- Benjamin L. Palleiko, Chief Executive Officer and Director

- Albert Cha, Director ,

Kalvista Pharmaceuticals Inc currently has 45 employees.

  News about Kalvista Pharmaceuticals Inc Key Personnel

KalVista Pharmaceuticals Appoints Benjamin L. Palleiko as CEO to Drive Growth and Overcome Challenges



KalVista Pharmaceuticals, a clinical stage pharmaceutical company specializing in oral, small molecule protease inhibitors, has recently announced the appointment of Benjamin L. Palleiko as its new Chief Executive Officer (CEO). This crucial leadership change comes at a challenging time for KalVista, as the company experienced a significant decline in its share value over the past month and recorded a substantial net loss in the past year. With Palleiko s appointment and Andrew Crockett s resignation, KalVista aims to tackle these obstacles head-on and ensure a more promising future.
A Shift in Leadership Strategy:
Effective immediately, Benjamin L. Palleiko transitions from his previous ro...






KALV Management Effectiveness KALV Revenue per Employee KALV Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.